全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

极低出生体重儿出生时骨代谢指标对代谢性骨病预测意义
Predictive Significance of Bone Metabolism Indexes at Birth in Very Low Birth Weight Infants for Metabolic Bone Disease

DOI: 10.12677/ACRP.2023.111001, PP. 1-6

Keywords: 极低出生体重儿,代谢性骨病,Very Low Birth Weight Infant, Metabolic Bone Disease

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨极低出生体重儿发生代谢性骨病的预测指标。方法:选取确诊代谢性骨病的129例极低出生体重儿设为病例组;同期47例非代谢性骨病极低出生体重儿为对照组。分析比较两组新生儿出生时血清钙、血磷、血钙磷乘积、血碱性磷酸酶等。结果:出院后确诊代谢性骨病的极低出生体重儿出生时平均血清钙、血磷、血钙磷乘积与对照组无统计学差异(P值分别为0.574、0.360、0.325);血碱性磷酸酶水平低于对照组,差异有统计学意义(P = 0.017);使用ROC曲线分析,血碱性磷酸酶曲线下面积为0.519;血碱性磷酸酶(241.5 U/L)对代谢性骨病的预测敏感性为84.5%,特异性为31.9%,95% CI:0.413~0.624。结论:MBDP极低出生体重儿出生时血碱性磷酸酶可能存在差异,但无助于预测代谢性骨病的发生。
Objective: To investigate the predictors of metabolic bone disease in very low birth weight infants. Methods: 129 very low birth weight infants diagnosed with metabolic bone disease were selected as the case group; 47 very low birth weight infants with non-metabolic bone disease during the same period were selected as the control group. The serum calcium, serum phosphorus, serum calcium and phosphorus product, and serum alkaline phosphatase at birth were analyzed and compared between the two groups of infants. Results: The mean serum calcium, serum phosphorus, and se-rum calcium and phosphorus product of very low birth weight infants diagnosed with metabolic bone disease after discharge were not significantly different from those in the control group (P values were 0.574, 0.360, and 0.325, respectively); The enzyme level of serum alkaline phosphate was lower than the control group, and the difference was statistically significant (P = 0.017). Using ROC curve analysis, the area under the curve of serum alkaline phosphatase was 0.519; The sensitivity of serum alkaline phosphatase (241.5 U/L) for the prediction of metabolic bone disease was 84.5%, the specificity was 31.9%, 95% CI: 0.413~0.624. Conclusions: There may be differences in serum alkaline phosphatase at birth in very low birth weight infants with MBDP, but they are not helpful in predicting the occurrence of metabolic bone disease.

References

[1]  常艳美, 林新祝, 张蓉, 刘喜红, 童笑梅, 陈平洋, 封志纯, 中国医师协会新生儿科医师分会营养专业委员会, 中国医师协会儿童健康专业委员会新生儿营养与健康管理学组, 中国当代儿科杂志编辑委员会. 早产儿代谢性骨病临床管理专家共识(2021年) [J]. 中国当代儿科杂志, 2021, 23(8): 761-772.
[2]  He, X.R., Liang, C., Yu, Y.Q., et al. (2021) Risk Factors for Metabolic Bone Disease of Prematurity in Very/Extremely Low Birth Weight Infants: A Multicenter Investigation in China. Chinese Journal of Contemporary Pediatrics, 23, 555-562.
[3]  Rehman, M.U. and Narchi, H. (2015) Metabolic Bone Disease in the Preterm Infant: Current State and Future Directions. World Journal of Methodology, 5, 115-121.
https://doi.org/10.5662/wjm.v5.i3.115
[4]  Chacham, S., Pasi, R., Chegondi, M., et al. (2020) Metabolic Bone Disease in Premature Neonates: An Unmet Challenge. Journal of Clinical Research in Pediatric Endocrinology, 12, 332-339.
https://doi.org/10.4274/jcrpe.galenos.2019.2019.0091
[5]  (1978) Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. Archives of Disease in Childhood, 53, 696.
https://doi.org/10.1136/adc.53.8.696-e
[6]  Harrison, C.M. and Gibson, A.T. (2013) Osteopenia in Preterm Infants. Archives of Disease in Childhood. Fetal and Neonatal Edition, 98, F272-F275.
https://doi.org/10.1136/archdischild-2011-301025
[7]  Harrison, C.M., Johnson, K. and MeKechnie, E. (2008) Osteopenia of Prematurity: A National Survey and Review of Practice. Acta Paediatrica, 97, 407-413.
https://doi.org/10.1111/j.1651-2227.2007.00721.x
[8]  Llorente-Pelayo, S., Docio, P., et al. (2020) Modified Se-rum ALP Values and Timing of Apparition of Knee Epiphyseal Ossification Centers in Preterm Infants with Cholestasis and Risk of Concomitant Metabolic Bone Disease of Prematurity. Nutrients, 12, 3854.
https://doi.org/10.3390/nu12123854
[9]  Hung, Y.L., Chen, P.C., Jeng, S.F., et al. (2011) Serial Measurements of Serum Alkaline Phosphatase for Early Prediction of Osteopaenia in Preterm Infants. Journal of Paediatrics and Child Health, 47, 134-139.
https://doi.org/10.1111/j.1440-1754.2010.01901.x
[10]  Viswanathan, S., Khasawneh, W., McNelis, K., et al. (2014) Metabolic Bone Disease: A Continued Challenge in Extremely Low Birth Weight Infants. Journal of Parenteral and En-teral Nutrition, 38, 982-990.
https://doi.org/10.1177/0148607113499590
[11]  Figueras-Aloy, J., álvarez-Domínguez, E., Pérez-Fernández, J.M., et al. (2014) Metabolic Bone Disease and Bone Mineral Density in Very Preterm Infants. The Journal of Pediatrics, 164, 499-504.
https://doi.org/10.1016/j.jpeds.2013.10.089
[12]  Backstr?m, M.C., Kouri, T., Kuusela, A.L., et al. (2000) Bone Isoenzyme of Serum Alkaline Phosphatase and Serum Inorganic Phosphate in Metabolic Bone Disease of Prematurity. Acta Paediatrica, 89, 867-873.
https://doi.org/10.1111/j.1651-2227.2000.tb00395.x
[13]  Abdallah, E.A.A., Said, R.N., Mosallam, D.S., et al. (2016) Serial Serum Alkaline Phosphatase as an Early Biomarker for Osteopenia of Prematurity. Medicine (Baltimore), 95, e4837.
https://doi.org/10.1097/MD.0000000000004837
[14]  Kavurt, S., Demirel, N., Yücel, H., Unal, S., et al. (2021) Evaluation of Radiologic Evidence of Metabolic Bone Disease in Very Low Birth Weight Infants at Fourth Week of Life. Journal of Perinatology, 41, 2668-2673.
https://doi.org/10.1038/s41372-021-01065-y
[15]  Ukarapong, S., Venkatarayappa, S.K.B., Navarrete, C. and Berkovitz, G. (2017) Risk Factors of Metabolic Bone Disease of Prematurity. Early Human Development, 112, 29-34.
https://doi.org/10.1016/j.earlhumdev.2017.06.010
[16]  Moreira, A., Swischuk, L., Malloy, M., et al. (2014) Para-thyroid Hormone as a Marker for Metabolic Bone Disease of Prematurity. Journal of Perinatology, 34, 787-791.
https://doi.org/10.1038/jp.2014.97

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133